MEATTINI, ICRO
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 12.417
EU - Europa 7.837
AS - Asia 1.985
AF - Africa 47
SA - Sud America 11
Continente sconosciuto - Info sul continente non disponibili 3
OC - Oceania 2
Totale 22.302
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 12.398
RU - Federazione Russa 3.224
PL - Polonia 1.384
IT - Italia 1.080
IE - Irlanda 919
SE - Svezia 622
SG - Singapore 566
CN - Cina 505
HK - Hong Kong 500
IN - India 156
DE - Germania 151
JO - Giordania 140
FI - Finlandia 136
GB - Regno Unito 94
UA - Ucraina 57
ES - Italia 52
VN - Vietnam 38
KR - Corea 33
CH - Svizzera 32
CI - Costa d'Avorio 31
FR - Francia 25
TR - Turchia 25
BE - Belgio 20
CA - Canada 16
NL - Olanda 12
CZ - Repubblica Ceca 11
BR - Brasile 10
JP - Giappone 7
BG - Bulgaria 5
IL - Israele 4
AT - Austria 3
CY - Cipro 3
DZ - Algeria 3
EG - Egitto 3
EU - Europa 3
LT - Lituania 3
MA - Marocco 3
MU - Mauritius 3
OM - Oman 3
DK - Danimarca 2
GR - Grecia 2
ID - Indonesia 2
MX - Messico 2
PH - Filippine 2
TN - Tunisia 2
AR - Argentina 1
AU - Australia 1
GL - Groenlandia 1
IR - Iran 1
LY - Libia 1
NG - Nigeria 1
NZ - Nuova Zelanda 1
PT - Portogallo 1
RO - Romania 1
RS - Serbia 1
Totale 22.302
Salva come PNG Salva come JPEG
Città #
Santa Clara 1.895
Fairfield 1.706
Warsaw 1.384
Dublin 916
Ashburn 880
Woodbridge 781
Seattle 773
Chandler 771
Cambridge 669
Houston 644
Wilmington 581
Singapore 445
Lawrence 363
Altamura 358
Ann Arbor 318
Hong Kong 308
Princeton 257
Florence 213
Moscow 182
Beijing 164
Boston 156
Buffalo 152
Mumbai 121
Dearborn 118
San Diego 116
Shanghai 97
Medford 90
Boardman 80
Jacksonville 76
Kent 59
New York 56
Barcelona 42
Munich 39
Guangzhou 37
Milan 33
Rome 33
Seoul 33
Falls Church 32
Los Angeles 32
Abidjan 31
Dong Ket 30
Norwalk 30
Bern 26
Hillsboro 24
Pune 24
Helsinki 23
London 23
Izmir 21
Yubileyny 21
Andover 19
Brussels 19
Redwood City 19
Nanjing 18
Shenzhen 18
Toronto 12
Prato 11
West Jordan 11
Brno 10
Garden City 10
Bologna 9
Hangzhou 9
Phoenix 9
Charlotte 8
Kilburn 8
Laurel 7
Naples 7
Verona 7
Wuhan 7
Detroit 6
Paris 6
Frankfurt am Main 5
Paese 5
Qingdao 5
Redmond 5
San Mateo 5
Sofia 5
Somma Vesuviana 5
São Paulo 5
Berlin 4
Chongqing 4
Falkenstein 4
Hefei 4
Maddaloni 4
Pisa 4
Romainville 4
Romola 4
San Quirino 4
Xi'an 4
Zhengzhou 4
Acerra 3
Alice Castello 3
Andria 3
Bastia 3
Blida 3
Brescia 3
Böblingen 3
Cambiago 3
Campi Bisenzio 3
Castelliri 3
Cerea 3
Totale 15.610
Salva come PNG Salva come JPEG
Nome #
Stereotactic body radiotherapy for cardiac and paracardiac metastases: University of Florence experience. 244
Role of chemotherapy in nasopharyngeal carcinoma 242
Hypofractionation in prostate cancer: radiobiological basis and clinical appliance. 241
Postmastectomy radiotherapy for locally advanced breast cancer receiving neoadjuvant chemotherapy. 227
Radiosensitivity in the breast cancer management scenario: Another step forward? 226
Multiple cutaneous angiosarcomas after breast conserving surgery and bilateral adjuvant radiotherapy: an unusual case and review of the literature. 212
hERG1 channel expression associates with molecular subtypes and prognosis in breast cancer. 207
The Evolving Role of Ultrasound Guided Percutaneous Laser Ablation in Elderly Unresectable Breast Cancer Patients: A Feasibility Pilot Study 205
Non-pegylated liposomal doxorubicin in combination with cyclophosphamide or docetaxel as first-line therapy inmetastatic breast cancer: a retrospective analysis. 198
Efficacy and tolerability of cyberknife stereotactic robotic radiotherapy for primary or secondary orbital lesions: A single-center retrospective experience 186
In Regard to Vaidya et al 184
Accelerated partial breast irradiation using intensity modulated radiotherapy versus whole breast irradiation: Health-related quality of life final analysis from the Florence phase 3 trial 170
Role of magnetic resonance imaging in the preoperative staging and work-up of patients affected by invasive lobular carcinoma or invasive ductolobular carcinoma 159
Stereotactic vacuum-assisted breast biopsy: Comparison between 11- and 8-gauge needles 157
SAFE trial: an ongoing randomized clinical study to assess the role of cardiotoxicity prevention in breast cancer patients treated with anthracyclines with or without trastuzumab 150
A PPAR gamma agonist protects against oral mucositis induced by irradiation in a murine model 148
Accelerated partial breast irradiation using intensity-modulated radiotherapy versus whole breast irradiation: 5-year survival analysis of a phase 3 randomised controlled trial 148
Microinvasive breast cancer: pathological parameters, cancer subtypes distribution, and correlation with axillary lymph nodes invasion. Results of a large single-institution series 145
Use of an alpha lipoic, methylsulfonylmethane and bromelain dietary supplement (Opera®) for chemotherapy-induced peripheral neuropathy management, a prospective study 142
Auto-planning for VMAT accelerated partial breast irradiation 141
Exclusive endocrine therapy or partial breast irradiation for women aged ≥70  years with luminal A-like early stage breast cancer (NCT04134598 – EUROPA): Proof of concept of a randomized controlled trial comparing health related quality of life by patient reported outcome measures 141
Triple Negative Apocrine Carcinomas as a Distinct Subtype of Triple Negative Breast Cancer: A Case-control Study 136
Peroxisome proliferator activated receptor-gamma stimulation for prevention of 5-fluorouracil-induced oral mucositis in mice 135
Combined modality therapy for thoracic and head and neck cancers: a review of updated literature based on a consensus meeting 134
A national multicenter study on 1072 DCIS patients treated with breast-conserving surgery and whole breast radiotherapy (COBCG-01 study) 134
External accelerated partial breast irradiation for ductal carcinoma in situ: long-term follow-up from a phase 3 randomized trial 133
Current trends and outcomes of breast reconstruction following nipple-sparing mastectomy: results from a national multicentric registry with 1006 cases over a 6-year period 132
Loco-regional recurrence in 2064 patients with breast cancer treated with mastectomy without adjuvant radiotherapy. 131
A PPAR-gamma agonist protects from radiation-induced intestinal toxicity 130
Aprepitant as prophylaxis of chemotherapy-induced nausea and vomiting in anthracyclines and cyclophosphamide-based regimen for adjuvant breast cancer 129
CyberKnife stereotactic radiotherapy for isolated recurrence in the prostatic bed 129
Prognostic factors in patients with locally advanced head and neck cancer treated with concurrent radiochemotherapy 128
Elderly patients affected by head and neck squamous cell carcinoma unfit for standard curative treatment: Is de-intensified, hypofractionated radiotherapy a feasible strategy? 128
Accelerated partial breast irradiation using intensity-modulated radiotherapy technique compared to whole breast irradiation for patients aged 70 years or older: subgroup analysis from a randomized phase 3 trial 126
Soft tissue sarcomas: new opportunity of treatment with PARP inhibitors? 126
Benefit of ablative versus palliative-only radiotherapy in combination with nivolumab in patients affected by metastatic kidney and lung cancer 126
Docetaxel in Castration-Resistant Prostate Cancer: A Single-Centre Experience 125
Safety of concurrent adjuvant radiotherapy and chemotherapy for locally advanced soft tissue sarcoma 125
Role of core needle biopsy in primary breast lymphoma 124
Phase 2 placebo-controlled, single-blind trial to evaluate the impact of oral ibandronate on bone mineral density in osteopenic breast cancer patients receiving adjuvant aromatase inhibitors: 5-year results of the single-centre BONADIUV trial 123
A single-institution restrospective experience of brachytherapy in the treatment of pituitary tumors: transsphenoidal approach combined with (192)Ir-afterloading catheters. 122
Adjuvant trastuzumab in breast cancer: experience from the University of Florence. 122
Gamma Knife Radiosurgery in the management of single and multiple brain metastases 122
Ribociclib plus letrozole and concomitant palliative radiotherapy for metastatic breast cancer 122
Radiotherapy boost dose-escalation for invasive breast cancer after breast-conserving surgery: 2093 Patients treated with a prospective margin-directed policy 121
Systemic therapies and cognitive impairment for breast cancer: an overview of the current literature 121
Radiotherapy in the age of cancer immunology: Current concepts and future developments 120
BRCA mutation in breast cancer patients: Prognostic impact and implications on clinical management 120
Concurrent cyclophosphamide, methotrexate, and 5-fluorouracil chemotherapy and radiotherapy for early breast carcinoma. 119
Impact of hormonal status on outcome of ductal carcinoma in situ treated with breast-conserving surgery plus radiotherapy: Long-term experience from two large-institutional series 118
76P THE IMPACT OF A BREATHING-CONTROL SYSTEM ON TARGET MARGINS AND NORMAL TISSUE SPARING IN THE TREATMENT OF LUNG CANCER: ANALYSIS OF 12 CASES AT RADIOTHERAPY UNIT OF FLORENCE UNIVERSITY 117
Application of helical tomotherapy for the treatment of a right atrium angiosarcoma: A case report 117
In reply to: Anti-HER2 neoadjuvant treatment may have an impact on discordance between preoperative core needle biopsy and surgical specimen in early breast cancer 117
PV-0512: Accelerated partial breast irradiation for Luminal-A breast cancer: analysis from a phase 3 trial 116
Impact of molecular subtypes classification concordance between preoperative core needle biopsy and surgical specimen on early breast cancer management: single-institution experience and review of published literature 116
Stereotactic body radiotherapy with CyberKnife for cardiac malignancies 115
Impact of COVID-19 on patient–doctor interaction in a complex radiation therapy facility 115
Second-line chemotherapy with fotemustine in temozolomide-pretreated patients with relapsing glioblastoma: a single institution experience. 115
Prognostic role of human epidermal growth factor receptor 2 status in premenopausal early breast cancer treated with adjuvant tamoxifen. 115
A PPAR-gamma agonist attenuates pulmonary injury induced by irradiation in a murine model 114
Core needle biopsy for the assessment of unilateral male breast lesions 114
Prognostic value of positive human epidermal growth factor receptor 2 status and negative hormone status in patients with T1a/T1b, lymph node-negative breast cancer. 113
Predictive factors for additional non-sentinel lymph node involvement in breast cancer patients with one positive sentinel node 113
A new approach in patient QA: Beam delivery check and in-vivo dosimetry during radiotherapy treatment 112
Adjuvant radiotherapy after extrapleural pneumonectomy for mesothelioma. Prospective analysis of a multi-institutional series 112
Late relapse in testicular germ cell tumors. 112
Incidence of skin toxicity in squamous cell carcinoma of the head and neck treated with radiotherapy and cetuximab: A systematic review 111
Enhancement of Soft Tissue Sarcoma Cell Radiosensitivity by Poly(ADP-ribose) Polymerase-1 Inhibitors 111
Cancer stem cells: biology and potential therapeutic applications 110
Clinical outcome of stereotactic body radiotherapy for abdominal lymph node metastases. 110
Complete response in metastatic renal cell carcinoma after radiotherapy and everolimus: a clinical case and review of the literature 110
Two-stage implant based breast reconstruction: should we always exchange the tissue expander for an implant right away? 110
Ischemic stroke during cisplatin-based chemotherapy for testicular germ celltumor: case report and review of the literature. 108
A benchmark study on 883 nasopharyngeal cancer patients treated in two ItalianCentres from 1977 to 2000. Part II: evolving technical choices and toxicitypatterns. 108
Hypofractionated whole breast irradiation after conservative surgery for patients aged less than 60 years: a multi-centre comparative study 107
European Society for Radiotherapy and Oncology Advisory Committee in Radiation Oncology Practice consensus recommendations on patient selection and dose and fractionation for external beam radiotherapy in early breast cancer 107
Management of Stage II testicular seminoma over a period of 40 years. 105
Safety of eribulin mesylate and concomitant radiotherapy for metastatic breast cancer: a single-center experience 105
Radiation therapy after breast conserving surgery increases long-term breast conservation for DCIS patients 104
Partial breast irradiation for ductal carcinoma in situ: The Goldilocks principle? 104
Accelerated Partial-Breast Irradiation Compared With Whole-Breast Irradiation for Early Breast Cancer: Long-Term Results of the Randomized Phase III APBI-IMRT-Florence Trial 104
Cyberknife treatment for low and intermediate risk prostate cancer 103
Impact of age on cytotoxic-induced ovarian failure in breast cancer treated with adjuvant chemotherapy and triptorelin 102
Phyllodes tumours of the breast diagnosed as B3 category on image-guided 14-gauge core biopsy: Analysis of 51 cases from a single institution and review of the literature. 102
Beam delivery check and in-vivo dosimetry during breast radiotherapy treatment 102
Four-dimensional computed tomography in accelerated partial breast irradiation planning: single series from a phase III trial 101
Cutaneous and cardiac toxicity of concurrent trastuzumab and adjuvant breast radiotherapy: a single institution series. 100
"To clip or not to clip. That is no question!" 99
Assessment of a guideline-based heart substructures delineation in left-sided breast cancer patients undergoing adjuvant radiotherapy: Quality assessment within a randomized phase III trial testing a cardioprotective treatment strategy (SAFE-2014) 99
hERG1 channel expression in breast cancer: association with molecular parameters, pathological features and survival 99
Radiation therapy during the coronavirus disease 2019 (covid-19) pandemic in Italy: a view of the nation's young oncologists 99
Radiotherapy Timing in 4,820 patients with Breast Cancer: University of Florence Experience. 99
Role of radiotherapy boost in women with ductal carcinoma in situ: A single-center experience in a series of 389 patients 99
Combination of novel systemic agents and radiotherapy for solid tumors – Part II: An AIRO (Italian association of radiotherapy and clinical oncology) overview focused on treatment toxicity 99
Symptomatic leptomeningeal andintramedullary metastases from intracranial glioblastoma multiforme: a casereport. 98
Impact of a breathing-control system on target margins and normal-tissue sparing in the treatment of lung cancer: experience at the radiotherapy unit of Florence University. 98
The impact of young age on breast cancer outcome 97
Distinct HR expression patterns significantly affect the clinical behavior of metastatic HER2+ breast cancer and degree of benefit from novel anti-HER2 agents in the real world setting 97
Pegylated liposomal doxorubicin (Caelyx®) and oral vinorelbine in first-line metastatic breast cancer patients previously treated with anthracyclines. 97
The Potential Role of Intensity-modulated Proton Therapy in the Regional Nodal Irradiation of Breast Cancer: A Treatment Planning Study 97
Totale 12.868
Salva come PNG Salva come JPEG
Categoria #
all - tutte 72.558
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 72.558
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/20203.069 0 0 0 0 514 525 485 460 427 266 245 147
2020/20212.054 175 172 107 279 134 187 104 140 202 290 161 103
2021/20221.648 43 69 139 148 44 95 48 170 80 72 271 469
2022/20234.057 390 980 167 209 251 698 526 244 392 27 106 67
2023/20241.770 73 169 259 91 127 215 92 397 45 107 135 60
2024/20256.684 416 1.211 726 1.884 2.447 0 0 0 0 0 0 0
Totale 22.688